Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticHematopoietic Stem Cell TransplantationTransplantation ConditioningLeukemiaBlood Cell CountTransplantation ChimeraLiver TransplantationGraft SurvivalTissue DonorsHematopoietic Stem CellsLeukocyte CountBusulfanBone Marrow PurgingHistocompatibility TestingCyclophosphamideBone Marrow DiseasesHistocompatibilityHematopoiesisTransplantation, IsogeneicKidney TransplantationRecurrenceTime FactorsCombined Modality TherapyTreatment OutcomeMice, Inbred C57BLLeukemia, Myeloid, AcuteBone Marrow ExaminationT-LymphocytesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunosuppressive AgentsRemission InductionRadiation ChimeraPrecursor Cell Lymphoblastic Leukemia-LymphomaHematologic NeoplasmsPlatelet CountGraft RejectionAcute DiseaseLeukemia, MyeloidHepatic Veno-Occlusive DiseaseBone RemodelingTransplantation ImmunologyBone Marrow NeoplasmsImmunosuppressionLymphocyte DepletionColony-Forming Units AssayLymphoma, Non-HodgkinFlow CytometryGraft vs Host ReactionMyelodysplastic SyndromesRetrospective StudiesStem Cell TransplantationLeukocyte TransfusionLeukocytes, MononuclearGranulocyte Colony-Stimulating FactorHematologic DiseasesHeart TransplantationSurvival AnalysisPancytopeniaHLA AntigensChimeraSevere Combined ImmunodeficiencyBlood CellsCells, CulturedLymphocytesAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesLung TransplantationCyclosporinePeripheral Blood Stem Cell TransplantationLymphocyte TransfusionCell DifferentiationSpleenAntigens, CD34Actuarial AnalysisImmunophenotypingBone DensitySurvival RateCytarabineNuclear FamilyCarmustineGranulocytesOrgan TransplantationCytomegalovirus InfectionsEtoposidePrognosisMice, Inbred BALB CDisease-Free SurvivalGraft vs Tumor EffectAntibodies, MonoclonalCell CountGraft vs Leukemia EffectMelphalan